Why Beijing is targeting multinationals in new phase of the anti-corruption campaign
Special to WorldTribune.com By Willy Lam, East-Asia-Intel.com The high-profile exposure of alleged corruption practices by the China division of pharmaceutical giant GlaxoSmithKline (GSK) indicates that Beijing’s anti-graft campaign has entered a new level. That official mouthpieces such as CCTV, People’s Daily and Global Times have come out with bitter attacks against GSK, however, suggests that […]